ArticleERJ open research2025

Myostatin/Smad2/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia.

Adriana Núñez-Robainas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.